These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33814932)

  • 41. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.
    Tazzite A; Jouhadi H; Nadifi S; Aretini P; Falaschi E; Collavoli A; Benider A; Caligo MA
    Gynecol Oncol; 2012 Jun; 125(3):687-92. PubMed ID: 22425665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of MMTV-like LTR and LTR-env gene sequences in human breast cancer.
    Wang Y; Pelisson I; Melana SM; Holland JF; Pogo BG
    Int J Oncol; 2001 May; 18(5):1041-4. PubMed ID: 11295054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mouse mammary tumor virus (MMTV) - like exogenous sequences are associated with sporadic but not hereditary human breast carcinoma.
    Naccarato AG; Lessi F; Zavaglia K; Scatena C; Al Hamad MA; Aretini P; Menicagli M; Roncella M; Ghilli M; Caligo MA; Mazzanti CM; Bevilacqua G
    Aging (Albany NY); 2019 Sep; 11(17):7236-7241. PubMed ID: 31518337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.
    Stavropoulou AV; Fostira F; Pertesi M; Tsitlaidou M; Voutsinas GE; Triantafyllidou O; Bamias A; Dimopoulos MA; Timotheadou E; Pectasides D; Christodoulou C; Klouvas G; Papadimitriou C; Makatsoris T; Pentheroudakis G; Aravantinos G; Karydakis V; Yannoukakos D; Fountzilas G; Konstantopoulou I
    PLoS One; 2013; 8(3):e58182. PubMed ID: 23536787
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
    Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Sokolenko AP; Sokolova TN; Ni VI; Preobrazhenskaya EV; Iyevleva AG; Aleksakhina SN; Romanko AA; Bessonov AA; Gorodnova TV; Anisimova EI; Savonevich EL; Bizin IV; Stepanov IA; Krivorotko PV; Berlev IV; Belyaev AM; Togo AV; Imyanitov EN
    Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Mouse Mammary Tumor Virus With Human Breast Cancer: Histology, Immunohistochemistry and Polymerase Chain Reaction Analyses.
    Lawson JS; Mazzanti C; Civita P; Menicagli M; Ngan CC; Whitaker NJ; Hochman J; Braitbard O; Yosufi B; Glenn WK
    Front Oncol; 2018; 8():141. PubMed ID: 29868468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mouse mammary tumor virus-like gene sequences are present in lung patient specimens.
    Trejo-Avila LM; Zapata-Benavides P; Barrera-Rodríguez R; Badillo-Almaráz I; Saavedra-Alonso S; Zamora-Avila DE; Morán-Santibañez K; Garza-Sáenz JA; Tamez-Guerra R; Rodríguez-Padilla C
    Virol J; 2011 Sep; 8():451. PubMed ID: 21943279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
    Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
    Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse mammary tumor virus-like nucleotide sequences in canine and feline mammary tumors.
    Hsu WL; Lin HY; Chiou SS; Chang CC; Wang SP; Lin KH; Chulakasian S; Wong ML; Chang SC
    J Clin Microbiol; 2010 Dec; 48(12):4354-62. PubMed ID: 20881168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling.
    Palmieri G; Palomba G; Cossu A; Pisano M; Dedola MF; Sarobba MG; Farris A; Olmeo N; Contu A; Pasca A; Satta MP; Persico I; Carboni AA; Cossu-Rocca P; Contini M; Mangion J; Stratton MR; Tanda F
    Ann Oncol; 2002 Dec; 13(12):1899-907. PubMed ID: 12453858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low penetrance alleles as risk modifiers in familial and sporadic breast cancer.
    Esteban Cardeñosa E; de Juan Jiménez I; Palanca Suela S; Chirivella González I; Segura Huerta A; Santaballa Beltran A; Casals El Busto M; Barragán González E; Fuster Lluch O; Bermúdez Edo J; Bolufer Gilabert P
    Fam Cancer; 2012 Dec; 11(4):629-36. PubMed ID: 22926736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer.
    Abulkhair O; Al Balwi M; Makram O; Alsubaie L; Faris M; Shehata H; Hashim A; Arun B; Saadeddin A; Ibrahim E
    J Glob Oncol; 2018 Aug; 4():1-9. PubMed ID: 30199306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse mammary tumor virus-like sequences in human breast cancer.
    Lawson JS; Glenn WK; Salmons B; Ye Y; Heng B; Moody P; Johal H; Rawlinson WD; Delprado W; Lutze-Mann L; Whitaker NJ
    Cancer Res; 2010 May; 70(9):3576-85. PubMed ID: 20388779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.